Share
On February 1st, the College – in partnership with the College of Physicians and Surgeons, PharmaCare and other healthcare stakeholders – implemented updated pharmacy Methadone Maintenance Treatment (MMT) standards; the methadone product has now transitioned from a 1 mg/ml to 10 mg/ml.
The month of February was a transitional month, where pharmacists could dispense methadone 1 mg/ml for prescriptions written in January 2014 or methadone 10mg/ml for prescriptions written February 2014 and beyond.
As outlined in the new standards, pharmacists may not authorize the provision of home delivery for MMT. Home delivery may only be provided if the prescribing physician has determined that the patient has severe mobility restrictions and has provided written authorization for home delivery on the MMT CPP form.
The College will be monitoring the sales of the unflavoured 10 mg/ml methadone products being sold to pharmacies in BC. If your patient(s) requires the unflavoured 10mg/ml commercially available methadone, in the rare event that they are allergic to the cherry flavoured product, special authorization must be obtained through PharmaCare and the dispensing pharmacist must contact the College for appropriate dispensing requirements.
If you require more information on MMT guidelines please visit the College website.
- Methadone
Share
